Scammer Payback on MSN
Watch what happens when a virus locks a scammer out of his own computer
At first, it’s just another refund scam. Then everything changes. The scammer suddenly can’t control his own system—and the ...
An Ormond Beach mental health counselor charged with defrauding the U.S. government of over $262,000, was netted in the 2026 ...
Jason Finkelstein, a doctor based in Texas, collaborated with a cardiovascular testing company in South Florida to submit ...
India's cash economy may be digitising rapidly, but cash itself is far from disappearing. For one of India's largest cash ...
I’ve talked to so many educators, and I just don’t feel like this is making their lives easier,” said board member Liz ...
CMS launches its Medicare GLP-1 Bridge July 1, giving eligible Medicare Part D beneficiaries access to weight-loss GLP-1s at a $50 monthly copay through December 2027. For health systems and pharmacy ...
"We continue to make progress against our top priorities of maintaining strong margins, reducing our cost structure and moving the business towards sustainable profitability," said CEO, Secretary & ...
Neil Batlivala has spent seven years building a healthcare company that most of the tech industry has never heard of and that serves a patient population most of Silicon Valley ignores. But last month ...
The front-page Seattle Times article “WA patients agonize as Medicare AI program continues to delay care,” on April 27, addressed Medicare’s attempts to moderate care costs and reduce inappropriate ...
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) ...
A financially sustainable solution for how to cover GLP-1 drugs for obesity remains elusive. The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results